Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 206,673 | 94,972 | 40,682 | 32,062 | 25,223 |
| Operating Income | -206,673 | -94,972 | -40,682 | -32,062 | -25,223 |
| Interest Expense | 0 | 0 | 0 | 0 | 1,213 |
| Other Income | 4,429 | 11,024 | 7,671 | 908 | 48 |
| Pre-tax Income | -202,244 | -83,948 | -33,011 | -31,154 | -26,388 |
| Net Income Continuous | -202,244 | -83,948 | -33,011 | -31,154 | -26,388 |
| Net Income | $-202,244 | $-83,948 | $-32,811 | $-31,154 | $-26,388 |
| EPS Basic Total Ops | -13.09 | -5.45 | -2.22 | -2.54 | -5.07 |
| EPS Basic Continuous Ops | -13.09 | -5.45 | -2.23 | -2.54 | -5.07 |
| EPS Diluted Total Ops | -13.09 | -5.45 | -2.22 | -2.54 | -5.07 |
| EPS Diluted Continuous Ops | -13.09 | -5.45 | -2.23 | -2.54 | -5.07 |
| EPS Diluted Before Non-Recurring Items | -13.09 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-206,202 | $-94,860 | $-40,586 | $-31,985 | $-25,223 |